Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 14,500 | 14,130 | 5,520 | 7,110 |
| Gross Profit | 14,500 | 14,130 | 5,520 | 7,110 |
| Operating Expenses | 35,300 | 17,440 | 18,320 | 14,970 |
| Operating Income | -20,800 | -3,310 | -12,800 | -7,860 |
| Other Income | 190 | 2,110 | 180 | -550 |
| Pre-tax Income | -20,610 | -1,200 | -12,620 | -8,410 |
| Income Tax | 0 | 5,420 | 0 | 50 |
| Net Income Continuous | -20,610 | -6,620 | -12,620 | -8,460 |
| Net Income | $-20,610 | $-6,620 | $-12,620 | $-8,460 |
| EBITDA(a) | $-19,440 | $-2,000 | $-11,750 | $-6,690 |